Our Core Bio-Sensing Technology Consists of Three Major Components:
RAMAN
SPECTROMETER:
Using raman technology to digitize bodily fluid.
SMART
SOFTWARE:
Molecular fingerprinting to quantify results.
CALIBRATED
TEST RESULTS:
Proprietary machine learning algorithms.
Our Basic Process
Kaligia Biosciences’ Point of Care Technology
Kaligia Biosciences’ technology is based on in-vitro point-of-care devices, statistics-based algorithms, and analytics.

Product and Technology Development
Kaligia’s RBA device is in various stages of research and approval.

Rapid Biofluid Analyzer (RBA)
RBA is an in-vitro measurement device which is invasive for blood application and non-invasive for other bodily fluids such as saliva, urine and sweat. This lends to numerous potential applications in the biomedical field.
Applications:
-
Whole Blood Hemoglobin Test
– Hemoglobin (Hgb), Hematocrit (HCT), and Red Blood Cells (RBC) -
COVID Rapid Screener
– Glucose, Creatinine, Triglycerides, Cholesterol, Albumin, Total Protein -
Serum (in R&D)
– COVID-19, Influenza A, Influenza B -
Urine (in R&D)
Benefit:
- Portable Lab
- Optimized for Operator Safety
- Significantly decreased risk for contamination
- Results in under 3 minutes
Never Stop Learning
Kaligia Biosciences’ Acquisition Software and Analytics
Kaligia Biosciences employs statistics-based algorithms to calculate quantitative results on biofluid composition. These proprietary algorithms are continuously being improved upon as more research is conducted within our CLIA-certified laboratory.